Postpartum Evaluation of Nifedipine and Enalapril for Hypertension

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 850 participants.

Also called NCT07023003

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 850 participants (planned count) (from the registry)
Sponsor
Nebraska Methodist Health System (from the registry)
Registry
  • NCT NCT07023003
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07023003. Randomized; no masking; primary purpose treatment. Start 2025-07-11 (actual); primary completion 2028-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Postpartum Evaluation of Nifedipine and Enalapril for Hypertension
Acronym
PEACE
Condition
Hypertension in Pregnancy
Intervention (Drug)
Enalapril 10mg QD
Intervention (Drug)
Nifedipine 30mg XL BID
Lead sponsor
Nebraska Methodist Health System (class: other)
Collaborator
Methodist Hospital Foundation (class: not stated)

Record details

Record id
cardio:ct-nct07023003
Content hash
cf59d7b30755bb7413e8cf2df3eda2364638a6dae7e5e349322a222ad6da0648